Correlation between Forced Vital Capacity and Slow Vital Capacity for the assessment of respiratory involvement in Amyotrophic Lateral Sclerosis: a prospective study

References

• Pinto S, de Carvalho M. Breathing new life into treatment advances for respiratory failure in amyotrophic lateral sclerosis patients. Neurodegen Dis Manage. 2014;4:83–102.
   PubMedGoogle Scholar
• de Carvalho M, Matias T, Evangelista T, Pinto A, Sales Luís ML. Motor neuron disease presenting with respiratory failure. J Neurol Sci. 1996;139:117–22.
   PubMed Web of Science ®Google Scholar
• Fallat RJ, Jewitt B, Bass M, Kamm B, Norris F. Spirometry in amyotrophic lateral sclerosis. Arch Neurol. 1979;36:74–80.
   PubMed Web of Science ®Google Scholar
• Czaplinski A, Yen AA, Appel SH. Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population. J Neurol Neurosurg Psychiatry. 2006;77:390–2.
   PubMed Web of Science ®Google Scholar
• Lechtzin N, Wiener CM, Shade DM, Clawson L, Diette GB. Spirometry in the supine position improves de detection of diaphragmatic weakness in patients with amyotrophic lateral sclerosis. Chest. 2002;121:436–42.
   PubMed Web of Science ®Google Scholar
• Pinto S, Turkman A, Pinto A, Swash M, de Carvalho M. Predicting respiratory insufficiency in amyotrophic lateral sclerosis: The role of phrenic nerve studies. Clin Neurophysiol. 2009;120:941–6.
   PubMed Web of Science ®Google Scholar
• Schiffman PL, Belsh JM. Pulmonary function at diagnosis of amyotrophic lateral sclerosis. Rate of deterioration. Chest. 1993;103:508–13.
   PubMed Web of Science ®Google Scholar
• Ringel SP, Murphy JR, Alderson MK, Bryan W, England JD, Miller RG, et al. The natural history of amyotrophic lateral sclerosis. Neurology. 1993;43:1316–22.
   PubMed Web of Science ®Google Scholar
• Kaplan LM, Hollander D. Respiratory dysfunction in amyotrophic lateral sclerosis. Clin Chest Med. 1994;15:675–81.
   PubMed Web of Science ®Google Scholar
• Jackson CE, Rosenfeld J, Moore DH, Bryan WW, Barohn RJ, Wrench M, et al. A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patients. J Neurol Sci. 2001;191:75–8.
   PubMed Web of Science ®Google Scholar
• Pinto S, Pinto A, de Carvalho M. Do bulbar-onset amyotrophic lateral sclerosis patients have an earlier respiratory involvement than spinal-onset amyotrophic lateral sclerosis patients? Eura Medicophys. 2007;43:505–9.
   PubMedGoogle Scholar
• Morgan RK, McNally S, Alexander M, Conroy R, Hardiman O, Costello RW. Use of Sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis. Am J Respir Crit Care Med. 2005;171:269–74.
   PubMed Web of Science ®Google Scholar
• Velasco R, Salachas F, Munerati E, Le Forestier N, Pradat PF, Lacomblez L, et al. Nocturnal oxymetry in patients with amyotrophic lateral sclerosis: role in predicting survival. Rev Neurol (Paris). 2002;158:575–8.
   PubMed Web of Science ®Google Scholar
• Pinto A, de Carvalho M, Evangelista T, Lopes A, Sales Luís ML. Nocturnal pulse oximetry: a new approach to establish the appropriate time for non-invasive ventilation in. Amyotrophic Lateral Sclerosis Patients. Amyotroph Lateral Scler. 2003;4:31–5.
   PubMed Web of Science ®Google Scholar
• Lyall RA, Donaldson N, Polkey MI, Leigh PN, Moxham J. Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain. 2001;124:2000–13.
   PubMed Web of Science ®Google Scholar
• Pinto S, de Carvalho M. Symmetry of phrenic nerve motor response in Amyotrophic Lateral Sclerosis. Muscle Nerve. 2010;42:822–5.
   PubMed Web of Science ®Google Scholar
• Pinto S, Geraldes R, Vaz N, Pinto A, de Carvalho M. Changes of the phrenic nerve motor response in amyotrophic lateral sclerosis: longitudinal study. Clin Neurophysiol. 2009;120:2082–5.
   PubMed Web of Science ®Google Scholar
• Pinto S, Pinto A, de Carvalho M. Phrenic nerve studies predict survival in Amyotrophic Lateral Sclerosis. Clin Neurophysiol. 2012;123:2454–9.
   PubMed Web of Science ®Google Scholar
• Pinto S, Swash M, de Carvalho M. Respiratory exercise in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2012;12:33–43.
   Web of Science ®Google Scholar
• Pinto S, de Carvalho M. The R of ALSFRS-R: does it really mirror functional respiratory involvement in amyotrophic lateral sclerosis? Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:120–3.
   PubMed Web of Science ®Google Scholar
• Hutchinson J. On the capacity of the lungs, and on the respiratory functions, with a view of establishing a precise and easy method of detecting disease by the spirometer. Med Chir Trans. 1846;29:137–252.
   PubMedGoogle Scholar
• Chhabra SK. Forced vital capacity, slow vital capacity, or inspiratory vital capacity: which is the best measure of vital capacity? J Asthma. 1998;35:361–5.
   PubMed Web of Science ®Google Scholar
• Brusasco V, Pellegrino A, Rodarte JR. Vital capacities in acute and chronic airway obstruction: dependence on flow and volume histories. Eur Respir J. 1997;10:1316–20.
   PubMed Web of Science ®Google Scholar
• O’Brien C, Guest PJ, Hill SL, Stockley RA. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax. 2000;55:635–42.
   PubMed Web of Science ®Google Scholar
• Chan ED, Irvin CG. The detection of collapsible airways contributing to airflow limitation. Chest. 1995;107:856–9.
   PubMed Web of Science ®Google Scholar
• Cohen J, Postma DS, Vink-Klooster K, van der Bij W, Verschuuren E, Ten Hacken NH, et al. FVC to slow inspiratory vital capacity ratio, a potential marker for small airways obstruction. Chest. 2007;132:1198–203.
   PubMed Web of Science ®Google Scholar
• Yuan W, He X, Xu Q-F, Wang HY, Casaburi R. Increased difference between slow and forced vital capacity is associated with reduced exercise tolerance in COPD patients. BMC Pulm Med. 2014;14:16. doi: 10.1186/1471-2466-14-16.
   PubMed Web of Science ®Google Scholar
• Pringle CE, Hudson AJ, Munoz DG, Kiernan JA, Brown WF, Ebers GC. Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria. Brain. 1992;115:495–520.
   PubMed Web of Science ®Google Scholar
• Gordon PH, Cheng B, Katz IB, Pinto M, Hays AP, Mitsumoto H, Rowland LP. The natural history of primary lateral sclerosis. Neurology. 2006;66:647–53.
   PubMed Web of Science ®Google Scholar
• Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–38.
   PubMed Web of Science ®Google Scholar
• Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis. 1983;127:725–34.
   PubMed Web of Science ®Google Scholar
• Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)–revised report of an EFNS task force. Eur J Neurol. 2012;19:360–75.
   PubMed Web of Science ®Google Scholar
• Miller RG, Rosenberg JA, Gelinas DF, Mitsumoto H, Newman D, Sufit R, et al. Practice parameter: The care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology. 1999;52:1311–23.
   PubMed Web of Science ®Google Scholar
• Pinto AC, Evangelista T, Carvalho M, Alves MA, Luis MS. Respiratory assistance with a non-invasive ventilator (Bipap) in MND/ALS patients: survival rates in a controlled trial. J Neurol Sci. 1995;129:19–26.
   PubMed Web of Science ®Google Scholar
• Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurology. 2006;5:140–7.
   PubMed Web of Science ®Google Scholar
• Bauer M, Czell D, Hartmann S, Goldman B, Müller D, Weber M. Limitations of sniff nasal pressure as an outcome measurement in amyotrophic lateral sclerosis patients in a clinical trial. Respiration. 2012;84:306–11.
   PubMed Web of Science ®Google Scholar
• American Thoracic Society statement. Evaluation of impairment/disability secondary to respiratory disease. Am Rev Respir Dis. 1982;126:945–51.
   PubMedGoogle Scholar
• Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999;169:13–21.
   PubMed Web of Science ®Google Scholar